Which regulatory body oversees tissue banking practices in the United States?

The Food and Drug Administration (FDA) is the primary regulatory body that oversees tissue banking practices in the United States. The FDA enforces regulations that ensure the safety, efficacy, and quality of human tissues intended for transplantation. This includes establishing guidelines on the collection, processing, storage, and distribution of tissues. The FDA's oversight is crucial in maintaining standards that prevent the transmission of infectious diseases and ensure the proper handling of tissues to protect patients receiving transplants.

The other organizations, while significant in their respective domains, do not primarily focus on regulating tissue banking practices. The National Institute of Health (NIH) primarily funds and conducts medical research, while the Centers for Disease Control and Prevention (CDC) focuses on public health and disease prevention but does not have the same regulatory authority over tissue banks. The American College of Surgeons (ACS) is an organization dedicated to improving surgical care and education but does not regulate tissue banking practices.